This podcast with speakers Linda Simmler, Switzerland, Frederick Barret, United States, and host Friederike Holze, Switzerland, is part of the Congress Preview podcast series from ECNP.

They explore the therapeutic potential of psychedelics like psilocybin, discussing both preclinical and clinical research. Topics include synaptic plasticity, neural circuits, and the role of psychedelics in treating depression, anxiety, and addiction. The conversation highlights key challenges such as establishing causal links between neuroplasticity and therapeutic effects, predicting patient responses, and navigating public perception and funding. Join them for their symposium at the 2025 ECNP congress in Amsterdam.

Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.